MARKY CORP.: auditor change — Marky Corp. dismisses Bolko & Associates, appoints Olayinka Oyebola & Co as new auditor

MARKY CORP.

On April 2, 2024, Audit Committee dismissed Bolko & Associates as independent registered public accounting firm.
Bolko's reports for fiscal 2023 contained no adverse opinion, disclaimer, or qualification.
No disagreements or reportable events occurred during the period.
Olayinka Oyebola & Co appointed as new auditor effective after April 2, 2024 10-K filing.
A letter from Bolko & Associates agreeing with disclosures is attached as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

MARKY CORP. dismissed Bolko & Associates, LLC as its auditor.

Action: dismissal
Auditor: Bolko & Associates, LLC

Exact text from the filing

On April 2, 2024, the Audit Committee of the Supervisory Board of Marky Corp. determined to dismiss Bolko & Associates, LLC ("Bolko & Associates") as our independent registered public accounting firm.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

MARKY CORP. engaged Olayinka Oyebola & Co as its auditor.

Action: engagement
Auditor: Olayinka Oyebola & Co

Exact text from the filing

Contemporaneous with the determination to dismiss Bolko & Associates, the Audit Committee appointed Olayinka Oyebola & Co as our independent registered public accounting firm effective immediately following the filing of our Annual Report on Form 10-K for the year ended January 31, 2024 on April 2, 2024, subject to completion of its standard client acceptance procedures and execution of an engagement letter.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001973047-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.